Related Articles
Effects of BRAF V600E and NRAS mutational status on the progression‑free survival and clinicopathological characteristics of patients with melanoma
Prognostic significance of tumour‑infiltrating lymphocytes for oestrogen receptor‑negative breast cancer without lymph node metastasis
Mutations in BRAF codons 594 and 596 predict good prognosis in melanoma
RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer
Molecular alterations in clinical stage III cutaneous melanoma: Correlation with clinicopathological features and patient outcome